Strikingly, co-detection of a high mRNA level of uPAR-del4/5 and PAI-1 in tumor tissue of STS patients with complete tumor resection is associated with a 19-fold increased risk of tumor-related death suggesting that both markers can be considered together for prognostic evaluation and may support future therapy stratification. This evidence concerns the gene PLAUR and neoplasm.